Characteristics of colorectal patients who discontinued oxaliplatin therapy.

被引：1
|
作者：
Buchholz, Alexander
Sahmoun, Abe E.
Kurniali, Peter C.
机构：
[1] Univ North Dakota, Sch Med & Hlth Sci, Grand Forks, ND USA
[2] Univ North Dakota, Sch Med & Hlth Sci, Fargo, ND USA
[3] Univ North Dakota, Sch Med & Hlth Sci, Sanford Canc Ctr, Bismarck, ND USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15155
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy
    Cao, Yanshuo
    Chang, Qing
    Zhang, Wenjiang
    Ornatsky, Olga
    Hedley, David
    Chen, Eric X.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) : 1195 - 1200
  • [42] Immunophenotypiic and functional characteristics of lymphocytes in patients with aplastic anemia on immunosuppressive therapy.
    Sarkisyan, GP
    Kalinina, IA
    Bulycheva, TI
    Mikhallova, EA
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2003, 48 (03): : 23 - 26
  • [43] Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer
    Gruenberger, Brigit
    Tamandl, Dietmar
    Schueller, Johannes
    Scheithauer, Werner
    Zielinski, Christoph
    Herbst, Friedrich
    Gruenberger, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1830 - 1835
  • [44] Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
    Ruff, Paul
    Ferry, David R.
    Lakomy, Radek
    Prausova, Jana
    Van Hazel, Guy A.
    Hoff, Paulo M.
    Cunningham, David
    Arnold, Dirk
    Schmoll, Hans J.
    Moiseyenko, Vladimir M.
    McKendrick, Joseph J.
    ten Tije, Albert J.
    Vishwanath, Raghu L.
    Bhargava, Pankaj
    Chevalier, Soazig
    Macarulla, Teresa
    Van Cutsem, Eric
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (01) : 18 - 26
  • [45] Health status of arthritis patients who discontinued rofecoxib.
    Michaud, Kaleb
    Wolfe, Frederick
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S321 - S322
  • [46] Network biomarkers in recovered psychosis patients who discontinued antipsychotics
    Soyolsaikhan Odkhuu
    Woo-Sung Kim
    Uyanga Tsogt
    Jie Shen
    Sahar Cheraghi
    Ling Li
    Fatima Zahra Rami
    Thi-Hung Le
    Keon-Hak Lee
    Nam-In Kang
    Sung-Wan Kim
    Young-Chul Chung
    Molecular Psychiatry, 2023, 28 : 3717 - 3726
  • [47] Observational Study of CML Italian Patients Who Discontinued TKIs
    Fava, Carmen
    Rege-Carmbrin, Giovanna
    Dogliotti, Irene
    Cerrano, Marco
    Berchialla, Paola
    Rosti, Gianantonio
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Martino, Bruno
    Gambacorti-Passerini, Carlo
    Abruzzese, Elisabetta
    Orlandi, Ester Maria
    Elena, Chiara
    Pregno, Patrizia
    Gozzini, Antonella
    Avanzini, Paolo
    Bergamaschi, Micaela
    Crugnola, Monica
    Bocchia, Monica
    Galimberti, Sara
    Rapezzi, Davide
    Iurlo, Alessandra
    Cattaneo, Daniele
    Latagliata, Roberto
    Breccia, Massimo
    Cedrone, Michele
    Santoro, Marco
    Annunziata, Mario
    Levato, Luciano
    Stagno, Fabio
    Cavazzini, Francesco
    Sgherza, Nicola
    Giai, Valentina
    Luciano, Luigiana
    Russo, Sabina
    Musto, Pellegrino
    Caocci, Giovanni
    Sora, Federica
    Iuliano, Francesco
    Lunghi, Francesca
    Specchia, Giorgina
    Pane, Fabrizio
    Baccarani, Michele
    Ferrero, Dario
    Saglio, Giuseppe
    BLOOD, 2017, 130
  • [48] Network biomarkers in recovered psychosis patients who discontinued antipsychotics
    Odkhuu, Soyolsaikhan
    Kim, Woo-Sung
    Tsogt, Uyanga
    Shen, Jie
    Cheraghi, Sahar
    Li, Ling
    Rami, Fatima Zahra
    Le, Thi-Hung
    Lee, Keon-Hak
    Kang, Nam-In
    Kim, Sung-Wan
    Chung, Young-Chul
    MOLECULAR PSYCHIATRY, 2023, 28 (09) : 3717 - 3726
  • [49] Risk of Recurrences in Patients With Unprovoked VTE Who Continued vs Discontinued Rivaroxaban Therapy After 3-Month Therapy
    Berger, Jeffrey
    Seheult, Roger
    Laliberte, Francois
    Crivera, Concetta
    Lejeune, Dominique
    Xiao, Yongling
    Schein, Jeff
    Lefebvre, Patrick
    Kaatz, Scott
    CHEST, 2016, 150 (04) : 1155A - 1155A
  • [50] Oxaliplatin therapy for the treatment of metastatic colorectal cancer - Introduction
    Goldberg, RM
    SEMINARS IN ONCOLOGY, 2002, 29 (05) : 1 - 2
12345